Mouraviev V - Search Results

1

Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.

Mouraviev V, Madden JF, Broadwater G, Mayes JM, Burchette JL, Schneider F, Smith J, Tsivian M, Wong T, Polascik TJ. Mouraviev V, et al. J Urol. 2009 Sep;182(3):938-47. doi: 10.1016/j.juro.2009.05.047. Epub 2009 Jul 17. J Urol. 2009. PMID: 19616259 Clinical Trial.

2

Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?

Mouraviev V, Broadwater G, Sun L, Mayes JM, Moul JW, Polascik TJ. Mouraviev V, et al. Urology. 2008 Jun;71(6):1020-3. doi: 10.1016/j.urology.2007.11.016. Epub 2008 Feb 11. Urology. 2008. PMID: 18267331

3

Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney.

Chen VH, Mayes JM, Mouraviev V, Polascik TJ. Chen VH, et al. Among authors: mouraviev v. Urology. 2008 Sep;72(3):716.e1-2. doi: 10.1016/j.urology.2007.12.067. Epub 2008 Mar 7. Urology. 2008. PMID: 18314162

4

Focal therapy for prostate cancer.

Polascik TJ, Mouraviev V. Polascik TJ, et al. Among authors: mouraviev v. Curr Opin Urol. 2008 May;18(3):269-74. doi: 10.1097/MOU.0b013e3282f9b3a5. Curr Opin Urol. 2008. PMID: 18382236 Review.

5

Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen.

Isariyawongse BK, Sun L, Bañez LL, Robertson C, Polascik TJ, Maloney K, Donatucci C, Albala D, Mouraviev V, Madden JF, Moul JW. Isariyawongse BK, et al. Among authors: mouraviev v. Urology. 2008 Oct;72(4):882-6. doi: 10.1016/j.urology.2008.02.021. Epub 2008 Apr 2. Urology. 2008. PMID: 18384857

6

Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.

Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V. Polascik TJ, et al. Among authors: mouraviev v. Prostate. 2008 Sep 15;68(13):1380-6. doi: 10.1002/pros.20804. Prostate. 2008. PMID: 18543281

7

Impact of a cryotherapy training workshop on the adoption and utilization of cryotherapy in the community setting.

Mayes JM, Mouraviev V, Polascik TJ. Mayes JM, et al. Among authors: mouraviev v. Can J Urol. 2008 Aug;15(4):4147-52. Can J Urol. 2008. PMID: 18706140

8

Focal therapy for prostate cancer: pathologic basis.

Mouraviev V, Madden JF. Mouraviev V, et al. Curr Opin Urol. 2009 Mar;19(2):161-7. doi: 10.1097/MOU.0b013e328323f62b. Curr Opin Urol. 2009. PMID: 19188770 Review.

9

Nerve-sparing focal cryoablation of prostate cancer.

Polascik TJ, Mayes JM, Mouraviev V. Polascik TJ, et al. Among authors: mouraviev v. Curr Opin Urol. 2009 Mar;19(2):182-7. doi: 10.1097/MOU.0b013e328323f603. Curr Opin Urol. 2009. PMID: 19188772 Review.

10

Prostate cancer: the new landscape.

Moul JW, Mouraviev V, Sun L, Schroeck FR, Polascik TJ. Moul JW, et al. Among authors: mouraviev v. Curr Opin Urol. 2009 Mar;19(2):154-60. doi: 10.1097/mou.0b013e328323f5d6. Curr Opin Urol. 2009. PMID: 19195129 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters